Vessel imaging with viable tumor analysis for quantification of tumor angiogenesis
暂无分享,去创建一个
Sharon E Ungersma | N. van Bruggen | F. Peale | R. Carano | S. Ross | S. Yee | Jed Ross | Nicholas van Bruggen | J. Ross | Calvin C K Ho | G. Pacheco | Richard A D Carano | Sarajane Ross | Glenn Pacheco | Calvin Ho | Sharon Fong Yee | Franklin V Peale | S. Ungersma | S. E. Ungersma
[1] M. Prince. Gadolinium-enhanced MR aortography. , 1990, Radiology.
[2] Yoshimi Anzai,et al. MR angiography with an ultrasmall superparamagnetic iron oxide blood pool agent , 1997, Journal of magnetic resonance imaging : JMRI.
[3] R. Strecker,et al. Vessel size imaging in humans , 2005, Magnetic resonance in medicine.
[4] P. Kozlowski,et al. Longitudinal studies of angiogenesis in hormone-dependent Shionogi tumors. , 2007, Neoplasia.
[5] Arthur W. Toga,et al. Efficient Skeletonization of Volumetric Objects , 1999, IEEE Trans. Vis. Comput. Graph..
[6] Franklin Peale,et al. Neuropilin-1 Binds to VEGF121 and Regulates Endothelial Cell Migration and Sprouting* , 2007, Journal of Biological Chemistry.
[7] N. van Bruggen,et al. Quantification of viable tumor microvascular characteristics by multispectral analysis , 2008, Magnetic resonance in medicine.
[8] F. Peale,et al. Cross-species Vascular Endothelial Growth Factor (VEGF)-blocking Antibodies Completely Inhibit the Growth of Human Tumor Xenografts and Measure the Contribution of Stromal VEGF* , 2006, Journal of Biological Chemistry.
[9] G. Marchal,et al. In vivo animal functional MRI: Improved image quality with a body‐adapted mold , 2002, Journal of magnetic resonance imaging : JMRI.
[10] Haiying Tang,et al. High‐resolution MR imaging of mouse brain microvasculature using the relaxation rate shift index Q , 2004, NMR in biomedicine.
[11] S M Jorgensen,et al. Three-dimensional imaging of vasculature and parenchyma in intact rodent organs with X-ray micro-CT. , 1998, The American journal of physiology.
[12] Walter Heindel,et al. Antiangiogenic tumor treatment: early noninvasive monitoring with USPIO-enhanced MR imaging in mice. , 2007, Radiology.
[13] M. Tessier-Lavigne,et al. Function blocking antibodies to neuropilin-1 generated from a designed human synthetic antibody phage library. , 2007, Journal of molecular biology.
[14] N. van Bruggen,et al. Quantification of tumor tissue populations by multispectral analysis , 2004, Magnetic resonance in medicine.
[15] Samuel Valable,et al. Assessment of blood volume, vessel size, and the expression of angiogenic factors in two rat glioma models: a longitudinal in vivo and ex vivo study , 2008, NMR in biomedicine.
[16] D Le Bihan,et al. Contribution of Sinerem® used as blood‐pool contrast agent: Detection of cerebral blood volume changes during apnea in the rabbit , 1996, Magnetic resonance in medicine.
[17] F. Peale,et al. Bv8 regulates myeloid-cell-dependent tumour angiogenesis , 2007, Nature.
[18] E L Ritman,et al. Imaging Angiogenesis with Three-Dimensional Microscopic Computed Tomography. , 2000, Current interventional cardiology reports.
[19] P. Choyke,et al. Imaging of angiogenesis: from microscope to clinic , 2003, Nature Medicine.
[20] Wolfhard Semmler,et al. Assessment of vascular remodeling under antiangiogenic therapy using DCE‐MRI and vessel size imaging , 2009, Journal of magnetic resonance imaging : JMRI.
[21] Matilde Inglese,et al. Microvessel density estimation in the human brain by means of dynamic contrast‐enhanced echo‐planar imaging , 2006, Magnetic resonance in medicine.
[22] J. Folkman,et al. Tumor Behavior in Isolated Perfused Organs: In Vitro Growth and Metastases of Biopsy Material in Rabbit Thyroid and Canine Intestinal Segment , 1966, Annals of surgery.
[23] Chieko Azuma,et al. Multispectral quantification of tissue types in a RIF‐1 tumor model with histological validation. Part I , 2007, Magnetic resonance in medicine.
[24] R. Jain,et al. Microvascular architecture in a mammary carcinoma: branching patterns and vessel dimensions. , 1991, Cancer research.
[25] M. Knopp,et al. Estimating kinetic parameters from dynamic contrast‐enhanced t1‐weighted MRI of a diffusable tracer: Standardized quantities and symbols , 1999, Journal of magnetic resonance imaging : JMRI.
[26] Geoff J M Parker,et al. Quantifying Antivascular Effects of Monoclonal Antibodies to Vascular Endothelial Growth Factor: Insights from Imaging , 2009, Clinical Cancer Research.
[27] Franklin Peale,et al. Blocking neuropilin-1 function has an additive effect with anti-VEGF to inhibit tumor growth. , 2007, Cancer cell.
[28] M. Décorps,et al. Vessel size imaging , 2001, Magnetic resonance in medicine.
[29] Y Usson,et al. In vivo assessment of tumoral angiogenesis , 2004, Magnetic resonance in medicine.
[30] A. Heerschap,et al. Characterisation of tumour vasculature in mouse brain by USPIO contrast-enhanced MRI , 2008, British Journal of Cancer.
[31] B. Rosen,et al. Susceptibility contrast imaging of cerebral blood volume: Human experience , 1991, Magnetic resonance in medicine.
[32] B R Rosen,et al. Mr contrast due to intravascular magnetic susceptibility perturbations , 1995, Magnetic resonance in medicine.
[33] Wolfhard Semmler,et al. Volumetric computed tomography (VCT): a new technology for noninvasive, high-resolution monitoring of tumor angiogenesis , 2004, Nature Medicine.
[34] R. Chandra,et al. MR imaging of microvasculature , 2000, Magnetic resonance in medicine.
[35] G. Parker,et al. DCE-MRI biomarkers in the clinical evaluation of antiangiogenic and vascular disrupting agents , 2007, British Journal of Cancer.
[36] P. Tofts,et al. Measurement of the blood‐brain barrier permeability and leakage space using dynamic MR imaging. 1. Fundamental concepts , 1991, Magnetic resonance in medicine.
[37] B R Rosen,et al. NMR imaging of changes in vascular morphology due to tumor angiogenesis , 1998, Magnetic resonance in medicine.